Anna U. Loengard - 28 Nov 2022 Form 3/A - Amendment Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Director
Signature
/s/ Jessica Kirkland, as Attorney-in-Fact
Issuer symbol
CLOV
Transactions as of
28 Nov 2022
Net transactions value
$0
Form type
3/A - Amendment
Filing time
05 Jan 2023, 15:19:03 UTC
Date Of Original Report
30 Nov 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLOV Class A Common Stock 6,000 28 Nov 2022 Direct F1
holding CLOV Class A Common Stock 800 28 Nov 2022 By Son in a Custodial Account F1
holding CLOV Class A Common Stock 1,000 28 Nov 2022 By Daughter in a Custodial Account F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3, originally filed on November 30, 2022, amends the original filing to include shares which were previously inadvertently omitted from the Form 3 filing and one subsequent Form 4 filing.